{"nct_id":"NCT02596035","title":"An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2016-01-08","start_date_type":"ACTUAL","primary_completion_date":"2018-03-19","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-24","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["BMY"]}